Original Research
Published on 28 Nov 2024
A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV
in Vaccines and Molecular Therapeutics
- 2,609 views
Original Research
Published on 28 Nov 2024
in Vaccines and Molecular Therapeutics
Original Research
Published on 28 Nov 2024
in Vaccines and Molecular Therapeutics
Original Research
Published on 28 Nov 2024
in Vaccines and Molecular Therapeutics
Original Research
Published on 27 Nov 2024
in Vaccines and Molecular Therapeutics
Original Research
Published on 26 Nov 2024
in Vaccines and Molecular Therapeutics
Review
Published on 25 Nov 2024
in Vaccines and Molecular Therapeutics
Review
Published on 22 Nov 2024
in Vaccines and Molecular Therapeutics
Original Research
Published on 22 Nov 2024
in Vaccines and Molecular Therapeutics
Original Research
Published on 22 Nov 2024
in Vaccines and Molecular Therapeutics
Original Research
Published on 21 Nov 2024
in Vaccines and Molecular Therapeutics
Original Research
Published on 21 Nov 2024
in Vaccines and Molecular Therapeutics
Original Research
Published on 20 Nov 2024
in Vaccines and Molecular Therapeutics
Review
Published on 20 Nov 2024
in Vaccines and Molecular Therapeutics
Systematic Review
Published on 19 Nov 2024
in Vaccines and Molecular Therapeutics
Original Research
Published on 19 Nov 2024
in Vaccines and Molecular Therapeutics
Case Report
Published on 19 Nov 2024
in Vaccines and Molecular Therapeutics